Skip to content
LATEST
Health

International Guidelines Established for Personalized Phage Therapy

International experts have established the first standardized guidelines for personalized phage therapy to treat antibiotic-resistant infections, though the…

International Guidelines Established for Personalized Phage Therapy

An international coalition of 20 professional organizations and regulatory representatives has released the first coordinated clinical guidelines for personalized phage therapy. This framework addresses the use of bacteriophages—viruses that target and destroy specific bacteria—as a medical intervention for infections resistant to conventional antibiotics. The guidelines provide over 60 recommendations covering phage selection, manufacturing, quality control, and clinical administration.

Phage therapy offers a high degree of specificity compared to broad-spectrum antibiotics, as individual viruses are often limited to targeting particular bacterial strains. This precision necessitates a "phage match" process, where laboratories must verify the efficacy of a specific virus against a patient’s unique bacterial infection before treatment begins. The new guidelines mandate that such decisions be managed by multidisciplinary teams, including physicians, microbiologists, and specialized experts.

Despite the development of these standards, the guidelines do not currently endorse phage therapy as a routine medical treatment. Clinical evidence remains limited to observational studies, including a case series where 77% of patients showed clinical improvement and 61% achieved bacterial clearance. These results, while encouraging, lack the validation of large-scale, controlled clinical trials required to confirm efficacy and safety profiles.

Consequently, the framework restricts the use of phage therapy to cases where established treatments have failed or are contraindicated. The guidelines emphasize the necessity of rigorous documentation and standardized laboratory infrastructure to ensure that future data collection is reliable and comparable across international jurisdictions. Further research is required to determine the long-term viability of this approach as a standard clinical tool for managing antibiotic-resistant pathogens.

More stories

Latest news